8 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 9.7% per year over the past 5 years.
Operating margin has expanded, at -21.1% in the latest year.
Financial health
The company holds more cash ($32M) than total debt ($23M).
Total debt has grown slower than revenue (-3.0% vs 9.7% per year).
Operating income covered interest expense -3.3× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 2.3 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$67M
-$20M
58.3%
-21.1%
-$14M
$23M
$32M
2024
$56M
-$15M
59.5%
-24.5%
-$14M
$20M
$22M
2023
$53M
-$24M
56.1%
-43.5%
-$15M
$19M
$36M
2022
$46M
-$47M
46.9%
-101.1%
-$36M
$29M
$62M
2021
$48M
-$27M
57.4%
-49.8%
-$23M
$27M
$99M
2020
$42M
-$17M
60.6%
-36.2%
-$15M
$27M
$57M
2019
$40M
-$12M
53.4%
-23.0%
-$10M
$26M
$72M
2018
$32M
-$8M
52.6%
-15.0%
-$10M
$25M
$13M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$17M
-$4M
59.0%
-19.7%
-$11M
$23M
$22M
Dec '25
$17M
-$5M
55.4%
-29.9%
-$3M
$23M
$32M
Sep '25
$17M
-$7M
58.4%
-18.0%
$3M
$23M
$36M
Jun '25
$17M
-$4M
60.4%
-15.3%
-$3M
$23M
$30M
Mar '25
$15M
-$4M
58.9%
-21.7%
-$11M
$21M
$11M
Dec '24
$14M
-$4M
62.1%
-24.8%
$217000
$20M
$22M
Sep '24
$13M
-$5M
55.8%
-37.3%
-$2M
$20M
$22M
Jun '24
$15M
-$3M
60.1%
-17.2%
-$3M
$20M
$24M
Mar '24
$14M
-$3M
59.6%
-20.8%
-$9M
$20M
$27M
Dec '23
$14M
-$6M
59.2%
-37.4%
$8M
$19M
$36M
Sep '23
$13M
-$5M
57.4%
-37.8%
-$3M
$19M
$28M
Jun '23
$14M
-$5M
58.7%
-34.8%
-$10M
$19M
$31M
Mar '23
$11M
-$8M
47.2%
-68.6%
-$10M
$29M
$52M
Dec '22
$13M
-$14M
50.9%
-112.9%
-$6M
$29M
$62M
Sep '22
$15M
-$8M
59.2%
-53.1%
-$8M
$28M
$69M
Jun '22
$8M
-$15M
20.1%
-184.9%
-$13M
$28M
$76M
Mar '22
$10M
-$10M
44.0%
-93.1%
-$10M
$28M
$90M
Dec '21
$13M
-$7M
61.1%
-49.3%
-$7M
$27M
$99M
Sep '21
$12M
-$7M
55.2%
-53.1%
-$6M
$27M
$107M
Jun '21
$13M
-$6M
57.3%
-45.0%
-$5M
$27M
$113M
Valuation over time
How the market has priced XGN against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 1.3× (Mar '23) to 1.7× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is XGN growing its revenue and profit?
Over the past 5 years, EXAGEN INC.'s revenue has grown 9.7% per year. These are computed facts, not advice.
How much debt does XGN have?
As of FY2025, EXAGEN INC. reported $23M of total debt against $32M of cash; operating income covered interest expense -3.3×.
What is XGN's profit margin?
In FY2025, gross margin was 58.3%, operating margin -21.1%, and net margin -30.0%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.